Linguamatics said this week that it exceeded $10 million in sales last year outperforming both growth and sales expectations.
The company said in a statement that its increased sales came from a "boost in new customers and increased software licenses to existing customers in the pharmaceutical and healthcare sectors." This included 130 percent growth in healthcare sales plus increased sales in professional services, Linguamatics said.
Linguamatics developed and sells I2E, a software platform that uses natural language processing to identify and extract information from unstructured text such as scientific literature, patents, clinical trials data, electronic health records, news feeds, social media, and proprietary content and put it into a structured format for further analysis.
The company's customer base includes pharmaceutical companies, the US Food and Drug Administration, hospitals, cancer institutes, and academic research centers.